Paolo Bernasconi Selected Research

Paolo Bernasconi Research Topics

Disease

7	Leukemia 01/2022 - 06/2002
5	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 12/2019
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 04/2020 - 11/2004
4	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 12/2009 - 07/2004
3	Infections 01/2022 - 01/2021
3	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2019 - 11/2004
3	Neoplasms (Cancer) 06/2015 - 12/2006
2	Cytomegalovirus Infections (Inclusion Disease) 01/2022 - 01/2021
2	Primary Myelofibrosis (Myelosclerosis) 12/2021 - 01/2019
2	Hematologic Diseases (Blood Diseases) 01/2021 - 04/2006
2	Essential Thrombocythemia 01/2019 - 11/2008
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 03/2015 - 01/2005
2	Bronchiolitis Obliterans Syndrome 09/2012 - 04/2006
2	Chromosome Aberrations (Chromosome Abnormalities) 07/2012 - 12/2004
2	Acute Promyelocytic Leukemia 05/2011 - 08/2010
1	Hematologic Neoplasms (Hematological Malignancy) 01/2022
1	Encephalitis (Encephalitis, Rasmussen) 01/2021
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2020
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2020
1	Philadelphia Chromosome 12/2019
1	Polycythemia Vera 01/2019
1	Hypoxia (Hypoxemia) 01/2019
1	Pdgfra-Associated Chronic Eosinophilic Leukemia 06/2013
1	Multiple Myeloma 02/2010
1	Leukocytosis (Pleocytosis) 10/2009
1	Anemia 10/2009
1	Thrombocytopenia (Thrombopenia) 10/2009
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 08/2007
1	Nephrotic Syndrome (Syndrome, Nephrotic) 04/2006
1	Residual Neoplasm 10/2005
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2005
1	Disease Progression 11/2004
1	Thrombosis (Thrombus) 03/2002

Drug/Important Bio-Agent (IBA)

4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 01/2005
3	fludarabineIBA 01/2022 - 08/2007
3	Imatinib Mesylate (Gleevec)FDA Link 07/2012 - 07/2005
2	Busulfan (Busulfex)FDA Link 01/2022 - 01/2022
2	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 01/2022 - 01/2022
2	letermovirIBA 01/2022 - 01/2021
2	ruxolitinibIBA 12/2021 - 06/2013
2	Biological ProductsIBA 01/2021 - 01/2020
2	UbiquitinIBA 06/2015 - 12/2006
2	Pipobroman (Vercyte)FDA Link 02/2005 - 03/2002
1	Janus Kinase InhibitorsIBA 12/2021
1	Antiviral Agents (Antivirals)IBA 01/2021
1	CytokinesIBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2020
1	Tyrosine Kinase InhibitorsIBA 12/2019
1	Pharmaceutical PreparationsIBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 06/2015
1	Proteasome Endopeptidase Complex (Proteasome)IBA 06/2015
1	AnthracyclinesIBA 03/2015
1	Biomarkers (Surrogate Marker)IBA 01/2014
1	Arsenic Trioxide (Trisenox)FDA Link 05/2011
1	Dexamethasone (Maxidex)FDA LinkGeneric 02/2010
1	Bortezomib (Velcade)FDA Link 02/2010
1	Hemoglobins (Hemoglobin)IBA 10/2009
1	Dihydrotachysterol (AT 10)IBA 11/2008
1	Carrier Proteins (Binding Protein)IBA 12/2006
1	EnzymesIBA 12/2006
1	SteroidsIBA 04/2006
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 04/2006
1	Vincristine (Oncovin)FDA LinkGeneric 01/2005
1	Rituximab (Mabthera)FDA Link 01/2005
1	Phosphotransferases (Kinase)IBA 12/2004
1	Transcription Factors (Transcription Factor)IBA 12/2004
1	ChromatinIBA 12/2004
1	tyrosine receptor (receptor, tyrosine)IBA 12/2004
1	SurvivinIBA 11/2004
1	Codon (Codons)IBA 07/2004
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 06/2002

Therapy/Procedure

10	Therapeutics 01/2022 - 12/2004
8	Transplantation 01/2022 - 02/2010
8	Hematopoietic Stem Cell Transplantation 01/2022 - 04/2006
6	Stem Cell Transplantation 01/2022 - 04/2006
4	Cell Transplantation 01/2022 - 01/2020
2	Haploidentical Transplantation 10/2020 - 01/2020
1	Traction 01/2021
1	Drug Therapy (Chemotherapy) 03/2015
1	Photopheresis 09/2012
1	Immunotherapy 01/2005
1	Combination Drug Therapy (Combination Chemotherapy) 01/2005